Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2024 08:00 ET | Source: Compass Therapeutics

Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
August 02, 2022 08:00 ET | Source: Compass Therapeutics

Compass Therapeutics to Present at the 13th Annual Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...
August 01, 2022 16:30 ET | Source: Surface Oncology, Inc.

Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
August 05, 2020 16:31 ET | Source: Prevail Therapeutics

Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference

NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...
August 05, 2020 11:59 ET | Source: Surface Oncology, Inc.

Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
August 06, 2019 08:33 ET | Source: Aptinyx Inc.

Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference

EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
September 12, 2016 11:00 ET | Source: Aidikoff, Uhl & Bakhtiari

Aidikoff, Uhl & Bakhtiari Announces the Filing of a FINRA Arbitration Claim Seeking More than $1.1 Million On Behalf Of Former Customer of Wedbush Securities, Inc. broker Mark Heiden

BEVERLY HILLS, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Aidikoff, Uhl & Bakhtiari announces the filing of a FINRA arbitration seeking more than $1.1 million and its continuing investigation of...
August 10, 2016 16:01 ET | Source: Fate Therapeutics, Inc.

Fate Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference

SAN DIEGO, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
November 23, 2015 16:39 ET | Source: ZAGG Inc

ZAGG Presenting at the Wedbush Securities 2015 California Dreamin’ Technology|Consumer Conference

SALT LAKE CITY, Nov. 23, 2015 (GLOBE NEWSWIRE) -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile device accessories company, announced that Brad Holiday, chief financial officer, along with Kim...